Browse the evidence

Tirzepatide treatment yields greater improvements in physical function for patients with lower baseline physical function scores compared to those with higher baseline scores, despite similar magnitude of weight loss across all baseline levels.

If you have obesity and struggle with physical function (e.g., difficulty walking, climbing stairs), starting tirzepatide is highly recommended. You will likely lose weight just as effectively as someone who is more active, and you may experience the most dramatic improvements in your daily physical capabilities. Do not let current mobility issues stop you from seeking treatment.

Dietary interventions alone are insufficient for long-term obesity management due to biological resistance mechanisms that promote weight regain, necessitating a multi-modal approach including physical activity, behavioral therapy, pharmacotherapy, or surgery.

Stop looking for a single 'magic' diet that cures obesity. Sustainable weight management requires a combination of safe nutrition, regular physical activity, and behavioral support. If lifestyle changes are insufficient, consult a doctor about pharmacotherapy or surgery. Focus on long-term health improvements (blood pressure, glucose) rather than just the number on the scale, and be aware that biological mechanisms will fight weight loss, so ongoing maintenance strategies are essential.

In individuals with obesity and multiple long-term conditions (MLTCs), BMI reductions of ≥7% are associated with a lower risk of developing new obesity-related complications (ORCs) and reduced polypharmacy compared to stable BMI, whereas both significant weight loss and weight gain are associated with increased hazards for mental-health conditions, hospitalization, and mortality.

For people with obesity and multiple chronic conditions, losing weight (≥7%) can help prevent new diseases and reduce the number of medications. However, this population also faces higher risks of mental health issues, hospitalization, and mortality with both weight loss and gain compared to maintaining a stable weight. Treatment should be personalized, focusing on overall health outcomes rather than weight change alone.

Bariatric surgery remains the most efficacious treatment for obesity, producing sustained weight loss of approximately 20% or higher and superior metabolic improvements compared to pharmacotherapy alone.

If you have severe obesity, bariatric surgery is currently the most effective medical intervention for achieving significant, sustained weight loss and reversing metabolic diseases like type 2 diabetes. While it is invasive, it is considered safe and offers better long-term outcomes than medication alone for many patients.

Combining CPAP therapy with weight loss (via pharmacotherapy or lifestyle) yields greater improvements in cardiovascular risk markers than treating either condition alone.

If you have sleep apnea and are overweight, don't just focus on one. Using CPAP while also working to lose weight (through diet, exercise, or medication) provides the best protection for your heart and blood pressure. Treating just one condition leaves you at higher risk.

Ingesting 4.5g of Alaska Pollack Protein (APP) daily for 3 months improves neuromuscular efficiency (neural economy) in young healthy adults, evidenced by a greater reduction in motor unit discharge rates compared to whey protein, without increasing muscle mass.

If you are a young, healthy adult looking to improve how efficiently your muscles generate force, adding just 4.5 grams of Alaska Pollack Protein to your daily diet for 3 months may help. You likely won't see your muscles get bigger, but your nervous system may become more efficient at producing force, allowing you to generate the same strength with less neural effort compared to taking whey protein.

Ultrasound measurement of vastus lateralis (VL) muscle thickness, combined with body mass, provides a statistically accurate and ecologically valid prediction of whole-body and thigh fat-free mass (FFM) in resistance-trained men, serving as a viable alternative to DXA.

If you are a resistance-trained man, you can track your muscle gains using a portable ultrasound device focused on your vastus lateralis (side thigh) and your body weight. The study provides a specific formula: Whole Body FFM = -1.657 + (0.719 * Body Mass in kg) + (0.416 * VL Thickness in mm). This method is as accurate as DXA for this group and can be done in a gym setting, allowing you to monitor progress without expensive medical imaging.

In older adults, resistance training combined with whey protein supplementation induces distinct skeletal muscle metabolic adaptations—specifically upregulation of tryptophan-indole metabolites, branched-chain amino acids (leucine, isoleucine, valine), and urea cycle intermediates—in individuals who exhibit high hypertrophic responsiveness (upper tertile).

For older adults seeking muscle growth, resistance training combined with adequate protein (whey) is effective, but results vary significantly. High responders exhibit specific metabolic adaptations, including increased levels of tryptophan, branched-chain amino acids, and urea cycle intermediates. This suggests that individual metabolic profiles play a key role in hypertrophic responsiveness, and those with lower responses may require different strategies or higher stimuli to achieve similar gains.

Recovery status is an independent and significant predictor of lean body mass index, moderating the relationship between training load and muscle growth.

Monitor your daily readiness and soreness. If your recovery scores are low, your high training volume will not translate to muscle growth. Prioritize sleep and stress management to ensure your training load is effective.

Waist-to-hip ratio (WHR) is a significant predictor of ASCVD risk in individuals with ideal cardiovascular health, whereas BMI is not, suggesting that body fat distribution is more critical than total body weight for risk assessment in this group.

If you are metabolically healthy, your waist-to-hip ratio is a better predictor of heart disease risk than your weight. Consider tracking your waist and hip measurements to assess your risk, as visceral fat is more harmful than subcutaneous fat.

Modest combined improvements in sleep (11 min/day), physical activity (4.5 min/day MVPA), and nutrition (3 DQS points) are associated with a clinically meaningful 10% reduction in major adverse cardiovascular events (MACE).

You do not need to overhaul your entire life to significantly lower your heart disease risk. Instead, focus on making small, manageable improvements in three key areas every day: get 11 extra minutes of sleep, add 4.5 minutes of moderate-to-vigorous exercise (like brisk walking), and improve your diet quality by about 3 points (roughly adding 1/4 cup of vegetables). These modest, combined changes are associated with a 10% lower risk of major cardiovascular events.

Bariatric surgery (RYGB, SG, LAGB, BPD) significantly improves Type 2 Diabetes (T2DM) remission and lowers HbA1c levels compared to medical/lifestyle management (MT) in mid- to long-term follow-up.

For individuals with Type 2 Diabetes and obesity, bariatric surgery (specifically RYGB, SG, LAGB, or BPD) is significantly more effective than medical management or lifestyle changes alone for achieving diabetes remission and lowering HbA1c levels over the long term. While surgery carries risks and requires lifelong monitoring, it offers a superior path to metabolic health compared to non-surgical approaches for this population.

Roux-en-Y Gastric Bypass (RYGB) is the most favorable option for managing BMI and triglyceride (TG) levels in the mid-term, and is the second-best option for T2DM remission.

Roux-en-Y Gastric Bypass (RYGB) is a highly effective and well-studied surgical option for managing Type 2 Diabetes, particularly for improving BMI and triglyceride levels. It offers significant benefits for metabolic health and is a favorable choice for patients seeking a balance between efficacy and established surgical data.

High-carbohydrate overfeeding induces the greatest increase in 24-hour energy expenditure (EE) compared to other macronutrient compositions, while substrate oxidation shifts (e.g., fat vs. carbohydrate) are primarily driven by the availability of the ingested macronutrient.

If you are overfeeding, eating a high-carbohydrate diet will boost your daily energy expenditure more than high-fat or high-protein diets of the same caloric excess. Furthermore, your body will primarily oxidize the macronutrient you just ate (carbs for carb diets, fat for fat diets), rather than forcing a specific fuel source regardless of intake. This suggests that macronutrient composition is a key lever for managing metabolic rate and fuel selection during overfeeding.

Higher neighborhood-level availability of calories, carbohydrates, total fat, and saturated fat is positively associated with increased odds of being overweight in adults.

Your local food environment significantly impacts your weight risk. If you live in an area with high-calorie, high-fat food options, your odds of being overweight increase. To mitigate this, prioritize living in or visiting areas with more green space and lower saturated fat contributions, and be aware that 'healthy' labels on outlets may not reflect actual macronutrient content.

Higher scores on the Dietary Index for Gut Microbiota (DI-GM), specifically driven by beneficial components, are associated with significantly reduced all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic (CKM) syndrome stages 0-3.

For individuals with early-stage metabolic or kidney risks, prioritizing foods known to support gut health—such as fiber, fermented dairy, whole grains, and specific fruits/vegetables—may lower the risk of death from heart or other causes. This benefit appears distinct from just general dietary quality, suggesting specific gut-microbiome interactions are key.

High unfavorable dietary components (processed meats, red meats, refined grains, high-fat patterns) are associated with increased all-cause mortality but show no significant association with cardiovascular mortality after full adjustment.

Avoiding processed meats, refined grains, and high-fat patterns is important for overall survival, even if it doesn't directly predict heart disease death in this specific population. It contributes to general longevity.

Adherence to high dietary risk patterns (high DII score, high saturated fat/sodium, low fiber/omega-3) is significantly associated with increased odds of Major Adverse Cardiovascular Events (MACE), stroke, and cardiovascular mortality in patients with angiocardiopathy.

For patients with angiocardiopathy, adopting a low-inflammatory diet (low DII score) is strongly associated with reduced risk of major cardiovascular events, stroke, and death. This involves increasing intake of fruits, vegetables, fiber, and omega-3s, while reducing saturated fats, sodium, and added sugars. While this study is observational, the strong associations suggest that dietary optimization is a key component of managing cardiovascular risk in this population.

Treating cardiovascular, kidney, and metabolic diseases as interconnected entities sharing common pathophysiological mechanisms (CKM syndrome) is superior to treating them as separate, isolated conditions.

If you have high blood pressure, high blood sugar, and kidney issues, do not treat them in isolation. Seek a care model that addresses all three simultaneously, as they likely stem from the same underlying metabolic and inflammatory drivers. This integrated approach is the current standard of care for preventing progression to heart failure or end-stage kidney disease.

Resistance training interventions introduce significant interindividual response variation (heterogeneity) in strength and hypertrophy outcomes beyond random measurement error, as evidenced by increased variance in change scores compared to non-training controls.

Do not assume that a resistance training program that works for others will work identically for you. The paper confirms that resistance training introduces significant individual variability in strength and muscle growth. If you are not progressing, it may be due to your specific 'trainability' or response pattern rather than poor adherence. Consider that personalized adjustments to volume, intensity, or exercise selection may be necessary, as 'one size fits all' prescriptions are statistically less likely to optimize individual outcomes.

Obesity is a chronic disease requiring comprehensive clinical evaluation and staging (e.g., EOSS, Kings criteria) rather than reliance on BMI alone, as BMI has low sensitivity for adiposity and fails to capture complication risk.

Do not rely on BMI alone to assess your health risks. Ask your doctor for a comprehensive evaluation that includes staging criteria (like EOSS or Kings) and metabolic health markers (blood pressure, lipids, glucose). This ensures you get the right level of care, whether it's lifestyle changes, medication, or surgery, rather than just being told to 'lose weight'.

Consuming plant-based meat alternatives instead of animal meat reduces dietary acid load, evidenced by lower urinary excretion of sulfate, ammonium, phosphorus, and urea nitrogen, and higher urine pH and citrate levels in healthy adults.

If you are concerned about kidney health or urinary stone risk, switching from animal meat to plant-based meat alternatives (consuming at least 2 servings daily) can help reduce the acid load on your kidneys. This shift lowers harmful urinary acids and increases protective citrate, potentially offering benefits similar to eating more vegetables, without requiring a complete change in taste preferences.

The term 'non-responder' should be restricted to specific organs or physiological functions rather than applied to the whole individual, as exercise-induced adaptation is systemic and a lack of response in one area (e.g., VO2max) does not preclude adaptation in others (e.g., immune function or muscle metabolism).

If you aren't seeing improvements in your main goal (like running faster or lifting heavier), don't assume exercise isn't working for you. Your body is likely adapting in other ways, such as improved immune function, better blood flow, or metabolic health. The 'right' exercise for you might be different from what you are currently doing, so consider adjusting the type or intensity of your training rather than stopping.

Consumption of 5g/day of the human milk oligosaccharide 2'-fucosyllactose (2'-FL) for 6 weeks significantly increases the relative abundance of Bifidobacterium in the gut microbiota of healthy older adults.

For older adults looking to support gut health, consuming 5g of 2'-FL daily for 6 weeks is a well-tolerated intervention that significantly increases beneficial Bifidobacterium levels. While it did not change the primary immune score, it did increase HDL cholesterol and fasting insulin. Users should expect this effect to be reversible upon stopping supplementation.